Clinical Trial

A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to investigate LY3549492 in Chinese participants with type 2 diabetes. Participation in the study will last about 18 weeks.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-10; most recent amendment 2026-03-02.
Status change: Recruiting → Completed 2026-03-02
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT07073170
Lead Sponsor Eli Lilly and Company
Conditions Type 2 Diabetes
Enrollment 36 participants
Start Date 2025-07-25
Primary Completion 2026-01-27 (estimated)
Study Completion 2026-01-27 (estimated)
Updated on ClinicalTrials.gov 2026-03-03